Re: Ping: Louise
- From: louise <louise@xxxxxxxxxxxxxxx>
- Date: Tue, 05 Aug 2008 12:25:10 -0400
Susan wrote:
x-no-archive: yes
Biol Psychiatry. 2006 Dec 15;60(12):1343-9. Epub 2006 Aug 4. Links
Comment in:
Biol Psychiatry. 2008 Jan 1;63(1):e1; author reply e3.
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
DeBattista C, Belanoff J, Glass S, Khan A, Horne RL, Blasey C, Carpenter LL, Alva G.
Corcept Therapeutics, Menlo Park, California, USA. debattista@xxxxxxxxxxxx
BACKGROUND: Abnormalities in the hypothalamic pituitary adrenal axis have been implicated in the pathophysiology of psychotic major depression (PMD). Recent studies have suggested that the antiglucocorticoid, mifepristone might have a role in the treatment of PMD. The current study tested the efficacy of mifepristone treatment of the psychotic symptoms of PMD. METHODS: 221 patients, aged 19 to 75 years, who met DSM-IV and SCID criteria for PMD and were not receiving antidepressants or antipsychotics, participated in a double blind, randomized, placebo controlled study. Patients were randomly assigned to either 7 days of mifepristone (n = 105) or placebo (n = 116) followed by 21 days of usual treatment. RESULTS: Patients treated with mifepristone were significantly more likely to achieve response, defined as a 30% reduction in the Brief Psychiatric Rating Scale (BPRS). In addition, mifepristone treated patients were significantly more likely to achieve a 50% reduction in the BPRS Positive Symptom Scale (PSS). No significant differences were observed on measures of depression. CONCLUSION: A seven day course of mifepristone followed by usual treatment appears to be effective and well tolerated in the treatment of psychosis in PMD. This study suggests that the antiglucocorticoid, mifepristone, might represent an alternative to traditional treatments of psychosis in psychotic depression.
PMID: 16889757 [PubMed - indexed for MEDLINE]
Related Articles
• Clinical and biological effects of mifepristone treatment for psychotic depression. [Neuropsychopharmacology. 2006]
• Rapid reversal of psychotic depression using mifepristone. [J Clin Psychopharmacol. 2001]
• An open label trial of C-1073 (mifepristone) for psychotic major depression. [Biol Psychiatry. 2002]
• An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. [J Clin Psychiatry. 2005]
• A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. [J Clin Psychiatry. 2001]
• » See all Related Articles...
For clarification - I'm on the BP spectrum, non-psychotic, diagnosed BPII
.
- Follow-Ups:
- Re: Ping: Louise
- From: Susan
- Re: Ping: Louise
- References:
- Ping: Louise
- From: Susan
- Ping: Louise
- Prev by Date: Re: Long term progress
- Next by Date: Re: OT Loretta
- Previous by thread: Re: Ping: Louise
- Next by thread: Re: Ping: Louise
- Index(es):
Relevant Pages
|